The Maryland Medical Cannabis Commission is seeking to revoke the preliminary license of MaryMed LLC due to concerns about the company’s former parent company Vireo Health, according to a Baltimore Sun report. The commission said there was a “reasonable likelihood” that the company would not safeguard its medical cannabis products, citing the ongoing case in Minnesota where two former Vireo officers are accused of illegally transporting cannabis products from Minnesota to New York, where Vireo also holds a license.
“We’re deeply disappointed by the commission’s recommendation, particularly as it appears to be based on innuendo and misinformation instead of facts,” said MaryMed spokesman Andrew Mangini in the report.
Maryland regulators said that the company named the two accused executives in their November 2015 application. The commission also alleges that MaryMed officials failed to cooperate with Maryland investigators who were looking into the case.
Vireo owns one of the 12 companies approved last week for a cannabis business license in Pennsylvania, and state Health Department officials stood by that decision saying that the accused individuals no longer work for the company.
Health Department Spokeswoman April Hutcheson pointed out that Vireo has not been sanctioned in either Minnesota nor New York.
“Remember, the permits are given to business entities, not people,” she said in a Philadelphia Inquirer report.
Patrick Jameson, executive director of the MMCC said the agency would not award another license until the action against MaryMed is resolved.